Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Gregory Schwartz

Concepts (478)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Acute Coronary Syndrome
69
2024
254
16.680
 Why?
Anticholesteremic Agents
45
2023
129
12.360
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
52
2023
371
8.120
 Why?
Antibodies, Monoclonal, Humanized
35
2023
654
6.090
 Why?
Myocardial Infarction
42
2023
932
5.480
 Why?
Cholesterol, LDL
44
2023
306
5.020
 Why?
Lipoprotein(a)
15
2023
51
4.650
 Why?
Cardiovascular Diseases
32
2023
1725
3.800
 Why?
Proprotein Convertase 9
22
2023
61
3.470
 Why?
Coronary Disease
14
2020
347
3.170
 Why?
Angina, Unstable
18
2019
73
2.940
 Why?
Cholesterol, HDL
13
2020
184
2.820
 Why?
Sulfhydryl Compounds
10
2020
176
2.680
 Why?
Hypercholesterolemia
11
2023
90
2.640
 Why?
Diabetes Mellitus, Type 2
21
2024
2088
2.610
 Why?
Heptanoic Acids
20
2016
59
2.540
 Why?
Stroke
29
2023
1016
2.490
 Why?
Pyrroles
20
2016
179
2.370
 Why?
Quinazolinones
7
2021
19
2.290
 Why?
Dyslipidemias
6
2023
153
2.230
 Why?
Serine Proteinase Inhibitors
3
2020
34
1.750
 Why?
Myocardial Ischemia
16
2018
237
1.730
 Why?
Secondary Prevention
10
2019
220
1.670
 Why?
Thiazolidinediones
10
2017
134
1.670
 Why?
Cholesterol
10
2022
365
1.650
 Why?
Double-Blind Method
38
2023
1643
1.560
 Why?
Atherosclerosis
10
2022
342
1.550
 Why?
Hypoglycemic Agents
17
2022
1006
1.530
 Why?
Esters
9
2020
62
1.480
 Why?
Amides
9
2020
87
1.450
 Why?
Oxazoles
8
2019
29
1.440
 Why?
Treatment Outcome
56
2023
9006
1.410
 Why?
Cholesterol Ester Transfer Proteins
5
2016
17
1.400
 Why?
Thiophenes
8
2019
108
1.360
 Why?
Aged
65
2024
18944
1.240
 Why?
Risk Factors
39
2024
8606
1.230
 Why?
Coronary Artery Disease
6
2023
610
1.230
 Why?
Ventricular Fibrillation
3
2017
51
1.230
 Why?
Myocardial Contraction
12
2013
314
1.210
 Why?
Insulin Resistance
10
2018
1068
1.200
 Why?
Antibodies, Monoclonal
7
2023
1236
1.190
 Why?
C-Reactive Protein
11
2022
360
1.190
 Why?
Swine
33
2017
687
1.170
 Why?
Humans
140
2024
113531
1.150
 Why?
Metabolic Syndrome
4
2013
317
1.120
 Why?
Middle Aged
67
2024
26552
1.120
 Why?
Myocardium
21
2004
906
1.090
 Why?
Diabetic Angiopathies
2
2019
246
1.090
 Why?
Risk Assessment
18
2024
2953
1.080
 Why?
Myocardial Reperfusion Injury
5
2013
95
1.030
 Why?
Male
84
2023
55112
0.990
 Why?
Ischemic Attack, Transient
6
2018
62
0.980
 Why?
Female
98
2022
59115
0.950
 Why?
Heart
9
2009
609
0.950
 Why?
Lipoproteins, HDL
4
2019
74
0.950
 Why?
Proteins
3
2020
890
0.950
 Why?
Peripheral Arterial Disease
3
2020
381
0.940
 Why?
PPAR gamma
6
2022
179
0.920
 Why?
Proprotein Convertases
2
2014
14
0.880
 Why?
Insulin
7
2021
2076
0.800
 Why?
Fatty Acids, Nonesterified
4
2018
150
0.760
 Why?
Hospitalization
5
2019
1765
0.760
 Why?
Patient Admission
2
2021
175
0.750
 Why?
Coronary Circulation
18
2004
131
0.720
 Why?
Cardiovascular Agents
4
2021
125
0.710
 Why?
Molecular Targeted Therapy
2
2014
345
0.710
 Why?
Recurrence
11
2021
925
0.690
 Why?
Energy Metabolism
13
2004
717
0.680
 Why?
Triglycerides
4
2015
464
0.660
 Why?
Randomized Controlled Trials as Topic
16
2023
1205
0.650
 Why?
Lipid Metabolism
2
2014
438
0.620
 Why?
Adiponectin
2
2018
209
0.610
 Why?
Swine, Miniature
3
2013
70
0.600
 Why?
Venous Thrombosis
1
2020
142
0.600
 Why?
Heart Arrest
4
2017
293
0.600
 Why?
Brain Ischemia
5
2022
296
0.590
 Why?
Time Factors
18
2021
6032
0.590
 Why?
Ezetimibe
4
2023
24
0.570
 Why?
Biomarkers
17
2024
3389
0.550
 Why?
Aldosterone
1
2017
40
0.550
 Why?
Rosuvastatin Calcium
4
2022
17
0.540
 Why?
Venous Thromboembolism
1
2020
231
0.540
 Why?
Cardiovascular System
1
2018
124
0.530
 Why?
RNA, Small Interfering
6
2023
528
0.520
 Why?
Patient Readmission
2
2021
608
0.490
 Why?
Arteriosclerosis
2
2014
81
0.480
 Why?
Drug Therapy, Combination
6
2020
944
0.460
 Why?
Adenosine Triphosphate
11
2017
426
0.450
 Why?
Metformin
1
2017
273
0.440
 Why?
Veterans
3
2023
1248
0.430
 Why?
Animals
43
2017
31162
0.430
 Why?
Atrial Fibrillation
2
2022
325
0.430
 Why?
Diabetes Complications
3
2021
208
0.430
 Why?
Heart Failure
9
2022
1955
0.410
 Why?
Hemodynamics
11
2007
996
0.410
 Why?
Blood Pressure
11
2012
1521
0.410
 Why?
Magnetic Resonance Spectroscopy
14
2019
472
0.410
 Why?
Ventricular Function, Left
9
2004
469
0.410
 Why?
Phosphocreatine
10
1995
36
0.400
 Why?
Proportional Hazards Models
8
2019
1076
0.390
 Why?
Uncertainty
1
2012
90
0.390
 Why?
Dietary Fats
2
2013
286
0.380
 Why?
Coronary Vessels
7
2012
231
0.370
 Why?
Follow-Up Studies
10
2023
4384
0.370
 Why?
Glucose
5
2020
894
0.360
 Why?
Drug Administration Schedule
8
2019
712
0.360
 Why?
Reperfusion Injury
2
2005
251
0.360
 Why?
Research Design
3
2009
916
0.350
 Why?
Systole
7
2001
173
0.350
 Why?
Fluorobenzenes
2
2014
11
0.350
 Why?
Renal Insufficiency, Chronic
3
2021
486
0.340
 Why?
Phospholipases A2, Secretory
4
2014
21
0.330
 Why?
Risk
8
2018
807
0.320
 Why?
Diastole
5
2001
135
0.320
 Why?
Obesity
2
2013
2501
0.320
 Why?
Ischemia
1
2012
357
0.320
 Why?
Ventricular Dysfunction, Right
3
2007
216
0.320
 Why?
Cohort Studies
6
2023
4880
0.310
 Why?
Surgical Procedures, Operative
4
2017
208
0.310
 Why?
KATP Channels
1
2008
16
0.300
 Why?
Apolipoproteins B
5
2022
41
0.300
 Why?
Mortality
3
2017
282
0.290
 Why?
Chromans
3
2004
21
0.290
 Why?
Dose-Response Relationship, Drug
7
2019
1822
0.280
 Why?
Prognosis
6
2024
3318
0.280
 Why?
Survival Analysis
7
2018
1203
0.280
 Why?
Hypolipidemic Agents
3
2022
85
0.280
 Why?
Pyrimidines
2
2014
372
0.280
 Why?
Veterans Health
2
2020
166
0.280
 Why?
Sulfonamides
2
2014
442
0.270
 Why?
Phospholipids
3
2018
192
0.260
 Why?
Disease Models, Animal
7
2013
3470
0.260
 Why?
Incidence
5
2022
2310
0.260
 Why?
Subtilisins
2
2023
9
0.260
 Why?
Fenofibrate
1
2005
24
0.250
 Why?
Oxygen Consumption
8
2000
568
0.250
 Why?
Acute Disease
7
2012
885
0.240
 Why?
Acetates
3
2019
91
0.240
 Why?
Apolipoprotein A-I
2
2018
24
0.240
 Why?
Prediabetic State
2
2020
219
0.240
 Why?
Natriuretic Peptide, Brain
3
2024
94
0.240
 Why?
Clinical Trials, Phase III as Topic
2
2023
82
0.230
 Why?
Adrenergic beta-Antagonists
3
2013
286
0.230
 Why?
Cardiotonic Agents
3
2005
123
0.230
 Why?
Blood Glucose
5
2020
1823
0.230
 Why?
Morbidity
5
2017
275
0.230
 Why?
Cause of Death
5
2017
360
0.230
 Why?
Hyperemia
3
1991
42
0.230
 Why?
Syndrome
6
2007
328
0.220
 Why?
Dobutamine
4
2000
33
0.220
 Why?
Phosphorylation
3
2013
1537
0.220
 Why?
Thiazoles
2
2003
109
0.220
 Why?
Serine Endopeptidases
2
2014
101
0.210
 Why?
Indoles
3
2019
296
0.210
 Why?
Isoproterenol
3
1998
105
0.210
 Why?
Peroxisome Proliferator-Activated Receptors
4
2017
14
0.210
 Why?
Predictive Value of Tests
5
2017
1783
0.200
 Why?
Propensity Score
2
2021
225
0.200
 Why?
Insulin Receptor Substrate Proteins
2
2013
55
0.190
 Why?
Receptors, Cytoplasmic and Nuclear
1
2003
192
0.190
 Why?
Cost-Benefit Analysis
2
2020
542
0.190
 Why?
PPAR alpha
4
2022
52
0.190
 Why?
Diacetyl
1
2001
7
0.190
 Why?
Cytokines
2
2005
1795
0.190
 Why?
Peptide Fragments
3
2024
652
0.180
 Why?
Muscles
1
2022
313
0.180
 Why?
Hyperlipoproteinemia Type II
1
2021
26
0.180
 Why?
Mental Status and Dementia Tests
1
2021
21
0.180
 Why?
Coronary Artery Bypass
2
2019
196
0.180
 Why?
Cataract
1
2023
184
0.180
 Why?
Perioperative Care
2
2017
127
0.180
 Why?
Apolipoproteins
3
2012
36
0.170
 Why?
Myocardial Reperfusion
1
2000
50
0.170
 Why?
Phosphates
5
1992
154
0.170
 Why?
Glucagon-Like Peptide-1 Receptor
1
2020
73
0.170
 Why?
Calpain
2
2012
53
0.170
 Why?
Lipoproteins, LDL
2
2014
124
0.170
 Why?
Cadmium
1
2000
58
0.170
 Why?
Sodium
1
2020
184
0.170
 Why?
Matrix Metalloproteinases
1
2000
88
0.170
 Why?
Non-alcoholic Fatty Liver Disease
1
2022
244
0.160
 Why?
Potassium
1
2000
127
0.160
 Why?
Oncogenes
1
2000
104
0.160
 Why?
United States
6
2023
12137
0.160
 Why?
Proto-Oncogene Proteins c-akt
2
2013
394
0.160
 Why?
Injections, Subcutaneous
1
2019
134
0.160
 Why?
Renin-Angiotensin System
1
2019
72
0.160
 Why?
Alkaline Phosphatase
1
2019
141
0.160
 Why?
Multifactorial Inheritance
1
2019
120
0.150
 Why?
Adenylyl Cyclases
2
2016
82
0.150
 Why?
Early Termination of Clinical Trials
2
2015
14
0.150
 Why?
Risk Reduction Behavior
1
2020
200
0.150
 Why?
Immunoturbidimetry
1
2018
1
0.150
 Why?
Carotid Artery Diseases
1
2018
57
0.150
 Why?
Collagen
1
2000
411
0.150
 Why?
American Heart Association
1
2019
264
0.150
 Why?
Adrenergic beta-Agonists
1
1998
125
0.150
 Why?
Postoperative Complications
2
2019
2120
0.140
 Why?
Hypertension, Pulmonary
3
2012
1733
0.140
 Why?
Global Health
2
2017
287
0.140
 Why?
Citrate (si)-Synthase
1
2017
43
0.140
 Why?
Inflammation
6
2016
2444
0.140
 Why?
Pharmacogenetics
2
2016
149
0.140
 Why?
Signal Transduction
1
2009
4439
0.140
 Why?
Percutaneous Coronary Intervention
2
2019
445
0.140
 Why?
Australia
4
2019
205
0.140
 Why?
Epigenesis, Genetic
1
2021
515
0.140
 Why?
Administration, Intravenous
1
2017
122
0.130
 Why?
Drug Design
1
2017
146
0.130
 Why?
Clinical Trials as Topic
2
2018
922
0.130
 Why?
Lipoproteins
2
2014
157
0.130
 Why?
Inflammation Mediators
2
2013
469
0.130
 Why?
AMP-Activated Protein Kinases
1
2017
170
0.130
 Why?
Diet
2
2013
1076
0.130
 Why?
Platelet Aggregation Inhibitors
1
2019
395
0.130
 Why?
Anti-Arrhythmia Agents
2
2012
106
0.130
 Why?
Vasodilation
2
2013
414
0.120
 Why?
Heart Ventricles
6
2012
710
0.120
 Why?
Transcription Factors
1
2003
1497
0.120
 Why?
Hospital Mortality
1
2019
780
0.120
 Why?
Recombinant Proteins
1
2018
1214
0.120
 Why?
ATP Binding Cassette Transporter 1
1
2015
10
0.120
 Why?
Chromosomes, Human, Pair 16
1
2015
30
0.120
 Why?
Disease Progression
4
2018
2364
0.120
 Why?
Homeostasis
1
2018
561
0.120
 Why?
Environment
1
2016
326
0.120
 Why?
Stents
1
2018
463
0.120
 Why?
Simvastatin
1
2015
58
0.120
 Why?
Endovascular Procedures
1
2018
266
0.120
 Why?
Residence Characteristics
1
2016
272
0.120
 Why?
Aged, 80 and over
7
2020
6296
0.110
 Why?
Heart Rate
5
2001
705
0.110
 Why?
Linkage Disequilibrium
1
2015
239
0.110
 Why?
Serum Amyloid A Protein
3
2013
29
0.110
 Why?
Retrospective Studies
6
2018
12504
0.110
 Why?
Fasting
1
2015
242
0.110
 Why?
Phospholipases A
1
2014
94
0.110
 Why?
Mendelian Randomization Analysis
1
2013
43
0.110
 Why?
Ventricular Function, Right
1
1995
251
0.110
 Why?
Pancreatic Neoplasms
1
2000
721
0.110
 Why?
Acyl Coenzyme A
1
2013
29
0.100
 Why?
Heart Function Tests
1
2013
59
0.100
 Why?
Case-Control Studies
1
2019
2993
0.100
 Why?
Prospective Studies
2
2021
6189
0.100
 Why?
Hydroxy Acids
1
2012
3
0.100
 Why?
Decanoic Acids
1
2012
7
0.100
 Why?
Ischemic Preconditioning, Myocardial
1
2012
29
0.100
 Why?
Talin
1
2012
7
0.100
 Why?
Cardiolipins
1
2013
70
0.100
 Why?
Potassium Channel Blockers
1
2012
29
0.100
 Why?
Nitric Oxide Synthase Type III
1
2013
181
0.100
 Why?
Glyburide
1
2012
34
0.100
 Why?
Hypertension
1
2000
1051
0.100
 Why?
Europe
3
2019
331
0.100
 Why?
North America
3
2019
256
0.100
 Why?
Practice Guidelines as Topic
1
2019
1378
0.100
 Why?
1-Alkyl-2-acetylglycerophosphocholine Esterase
1
2012
20
0.100
 Why?
Polymorphism, Genetic
1
2015
603
0.100
 Why?
DNA
2
2013
1331
0.090
 Why?
Keto Acids
3
2019
12
0.090
 Why?
Tissue Plasminogen Activator
2
2013
204
0.090
 Why?
MAP Kinase Signaling System
1
2013
267
0.090
 Why?
Arteries
1
2013
244
0.090
 Why?
Death, Sudden, Cardiac
1
2012
160
0.090
 Why?
Fractures, Bone
1
2016
366
0.090
 Why?
United States Department of Veterans Affairs
3
2016
561
0.090
 Why?
Adult
8
2020
30245
0.090
 Why?
Myocardial Revascularization
3
2017
67
0.090
 Why?
Gene Expression Regulation
2
2013
2293
0.090
 Why?
RNA, Messenger
3
2015
2507
0.090
 Why?
Neoplasms
1
2023
2082
0.080
 Why?
Macrophages
1
2016
1233
0.080
 Why?
Phosphorus
4
1995
81
0.080
 Why?
MicroRNAs
1
2015
598
0.080
 Why?
Diabetes Mellitus
1
2016
896
0.080
 Why?
Vascular Diseases
2
2022
231
0.070
 Why?
Electrocardiography
1
2011
558
0.070
 Why?
Ventricular Pressure
1
2007
39
0.070
 Why?
Phosphatidylinositol 3-Kinases
1
2009
324
0.070
 Why?
Models, Biological
1
2014
1589
0.070
 Why?
Ultrasonography, Interventional
2
2018
120
0.070
 Why?
Survival Rate
1
2011
1634
0.070
 Why?
Reactive Oxygen Species
1
2009
516
0.070
 Why?
Age Factors
2
2007
2875
0.070
 Why?
Kaplan-Meier Estimate
2
2020
809
0.070
 Why?
Angiomatosis
1
2006
4
0.070
 Why?
Ultrasonography
1
2009
632
0.070
 Why?
Hemangioma, Capillary
1
2006
13
0.070
 Why?
Anti-Inflammatory Agents
1
2009
442
0.070
 Why?
Lactic Acid
2
1998
269
0.060
 Why?
Cerebrovascular Disorders
2
2017
82
0.060
 Why?
Chronic Disease
1
2011
1570
0.060
 Why?
Sus scrofa
1
2004
44
0.060
 Why?
alpha-Tocopherol
1
2004
25
0.060
 Why?
Arterial Occlusive Diseases
2
1982
73
0.060
 Why?
Linear Models
2
2013
767
0.060
 Why?
Antigen-Antibody Complex
1
2004
80
0.060
 Why?
CD40 Ligand
1
2004
37
0.060
 Why?
Least-Squares Analysis
1
2004
69
0.060
 Why?
Multicenter Studies as Topic
2
2012
248
0.060
 Why?
Economics, Pharmaceutical
1
2003
10
0.060
 Why?
Comorbidity
2
2019
1443
0.050
 Why?
Muscular Diseases
1
2004
101
0.050
 Why?
Guidelines as Topic
1
2005
241
0.050
 Why?
Regional Blood Flow
2
1996
407
0.050
 Why?
Lactates
2
1994
77
0.050
 Why?
Death
2
2019
106
0.050
 Why?
Creatine Kinase
1
2022
72
0.050
 Why?
Pharmacogenomic Testing
1
2022
53
0.050
 Why?
Multivariate Analysis
2
2017
1421
0.050
 Why?
Oxidation-Reduction
3
2012
912
0.050
 Why?
Goals
1
2022
147
0.050
 Why?
Verapamil
1
2001
32
0.050
 Why?
Receptors, Immunologic
1
2022
195
0.050
 Why?
Antioxidants
1
2004
527
0.050
 Why?
Organ Preservation Solutions
1
2001
37
0.050
 Why?
Liver Cirrhosis
1
2022
226
0.050
 Why?
Arrhythmias, Cardiac
1
2003
281
0.040
 Why?
Controlled Clinical Trials as Topic
1
2000
27
0.040
 Why?
Ventricular Dysfunction
1
2000
15
0.040
 Why?
Myocardial Stunning
1
2000
5
0.040
 Why?
Interleukin-6
3
2013
661
0.040
 Why?
Collagenases
1
2000
21
0.040
 Why?
Tissue Inhibitor of Metalloproteinases
1
2000
16
0.040
 Why?
Hexamethonium
1
2000
3
0.040
 Why?
Atropine
1
2000
25
0.040
 Why?
Dilatation, Pathologic
1
2000
54
0.040
 Why?
Health Care Costs
1
2003
381
0.040
 Why?
Cell Line
2
2016
2581
0.040
 Why?
Louisiana
1
2000
23
0.040
 Why?
Dipeptides
2
2012
46
0.040
 Why?
Occupations
1
2000
35
0.040
 Why?
Matrix Metalloproteinase 9
1
2000
114
0.040
 Why?
Pericardium
1
2000
51
0.040
 Why?
Ventricular Dysfunction, Left
1
2003
361
0.040
 Why?
Antigens, CD
1
2022
437
0.040
 Why?
Blood Chemical Analysis
1
2020
90
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2019
59
0.040
 Why?
Phospholipase A2 Inhibitors
1
2019
3
0.040
 Why?
Placebo Effect
1
2019
52
0.040
 Why?
Logistic Models
1
2004
1832
0.040
 Why?
New Zealand
1
2019
41
0.040
 Why?
Insulin Antagonists
1
1998
6
0.040
 Why?
Pulmonary Artery
2
2006
1012
0.040
 Why?
Ventricular Function
1
1999
57
0.040
 Why?
Drug Combinations
1
2000
285
0.040
 Why?
India
1
2019
136
0.040
 Why?
Hormone Antagonists
1
1998
30
0.040
 Why?
Hungary
1
2018
3
0.040
 Why?
Somatostatin
1
1998
52
0.040
 Why?
Placebos
1
2019
198
0.040
 Why?
Israel
1
2018
40
0.040
 Why?
Infusion Pumps
1
2018
31
0.040
 Why?
Microscopy, Electron
1
1999
397
0.040
 Why?
Netherlands
1
2018
64
0.040
 Why?
Elasticity
1
1999
187
0.040
 Why?
Protective Factors
1
2018
86
0.040
 Why?
Drug Interactions
1
2019
332
0.040
 Why?
Erythrocytes
1
2022
566
0.040
 Why?
Lipids
1
2001
558
0.040
 Why?
Blood Flow Velocity
1
1999
374
0.040
 Why?
Down-Regulation
1
2019
593
0.030
 Why?
Selection Bias
1
2017
33
0.030
 Why?
Echocardiography, Transesophageal
1
1997
90
0.030
 Why?
Attitude of Health Personnel
1
2004
970
0.030
 Why?
Drug Evaluation, Preclinical
1
2017
158
0.030
 Why?
Poverty Areas
1
2016
33
0.030
 Why?
Catheterization
1
1997
159
0.030
 Why?
Urban Health
1
2016
73
0.030
 Why?
Cognitive Dysfunction
1
2021
285
0.030
 Why?
Drug Discovery
1
2017
122
0.030
 Why?
Chi-Square Distribution
1
2017
493
0.030
 Why?
Rural Health
1
2016
67
0.030
 Why?
Cardiac Catheterization
1
2000
540
0.030
 Why?
Pharmacogenomic Variants
1
2016
33
0.030
 Why?
Internationality
1
2017
141
0.030
 Why?
Membrane Proteins
1
2022
1008
0.030
 Why?
Drug Industry
1
2017
103
0.030
 Why?
Albuminuria
1
2017
164
0.030
 Why?
Genome-Wide Association Study
1
2022
1157
0.030
 Why?
Fatty Acids
1
1998
380
0.030
 Why?
Physicians
1
2004
765
0.030
 Why?
Immunoglobulin M
2
2009
244
0.030
 Why?
Troponin
2
2007
44
0.030
 Why?
Myalgia
1
2015
11
0.030
 Why?
Creatinine
1
2017
434
0.030
 Why?
Angioplasty, Balloon, Coronary
1
1996
146
0.030
 Why?
Social Class
1
2016
203
0.030
 Why?
Thrombolytic Therapy
1
1996
117
0.030
 Why?
Receptors, LDL
1
2015
38
0.030
 Why?
Liver
1
2022
1630
0.030
 Why?
Chemotherapy, Adjuvant
1
1996
332
0.030
 Why?
Myositis
1
2015
43
0.030
 Why?
Carotid Intima-Media Thickness
1
2015
65
0.030
 Why?
Lidocaine
1
1994
40
0.030
 Why?
Hypertrophy, Left Ventricular
1
1995
101
0.030
 Why?
Stroke Volume
1
1997
510
0.030
 Why?
Electric Stimulation
1
1995
248
0.030
 Why?
Adenosine
2
1994
202
0.030
 Why?
Fat Emulsions, Intravenous
1
1994
27
0.030
 Why?
Osmolar Concentration
1
1994
163
0.030
 Why?
ATP-Binding Cassette Transporters
1
2015
122
0.030
 Why?
Analysis of Variance
1
2017
1208
0.030
 Why?
Glomerular Filtration Rate
1
2017
605
0.030
 Why?
Adenosine Diphosphate
1
1994
76
0.030
 Why?
Hyperglycemia
1
2017
292
0.030
 Why?
Mitochondria, Heart
1
1994
72
0.030
 Why?
NAD
1
1994
63
0.030
 Why?
Glycine
1
1994
151
0.030
 Why?
Patient Outcome Assessment
1
2014
122
0.030
 Why?
Perioperative Period
1
2013
47
0.030
 Why?
Oxidative Phosphorylation
1
1994
154
0.030
 Why?
Immunoglobulin G
2
2009
760
0.030
 Why?
Vascular Cell Adhesion Molecule-1
1
2013
35
0.030
 Why?
Heparin
1
1994
225
0.030
 Why?
Smoking
1
2000
1380
0.030
 Why?
Socioeconomic Factors
1
2016
1080
0.030
 Why?
Weight Gain
1
2016
454
0.030
 Why?
South Africa
1
2013
160
0.030
 Why?
Actinin
1
2012
13
0.030
 Why?
Patient Selection
1
1996
625
0.020
 Why?
Perfusion
1
1992
147
0.020
 Why?
Mathematics
1
1992
101
0.020
 Why?
Anticoagulants
1
1996
548
0.020
 Why?
Cardiac Output, Low
1
1992
66
0.020
 Why?
Electrophoresis, Polyacrylamide Gel
1
2012
305
0.020
 Why?
Biopsy
1
1995
1024
0.020
 Why?
Reperfusion
1
1991
35
0.020
 Why?
Disease-Free Survival
1
2013
617
0.020
 Why?
Patient Discharge
1
2017
770
0.020
 Why?
Dogs
2
1982
325
0.020
 Why?
Constriction
1
1990
43
0.020
 Why?
Alleles
1
2013
781
0.020
 Why?
Hypoglycemia
1
2015
386
0.020
 Why?
Equipment Design
1
1992
496
0.020
 Why?
Cognition Disorders
1
2014
476
0.020
 Why?
Mice
2
2016
14679
0.020
 Why?
Autoantibodies
2
2009
1349
0.020
 Why?
Polymorphism, Single Nucleotide
1
2016
1856
0.020
 Why?
Fibrin Fibrinogen Degradation Products
1
2009
79
0.020
 Why?
Thromboembolism
1
2009
92
0.020
 Why?
Databases, Factual
1
2013
1127
0.020
 Why?
Densitometry
1
2007
30
0.020
 Why?
Spectrin
1
2007
13
0.020
 Why?
Desmin
1
2007
24
0.020
 Why?
Sarcoplasmic Reticulum Calcium-Transporting ATPases
1
2007
37
0.020
 Why?
Kidney
1
2014
1179
0.020
 Why?
Heart Diseases
1
1990
327
0.020
 Why?
Calcium-Binding Proteins
1
2007
201
0.020
 Why?
ROC Curve
1
2007
442
0.020
 Why?
Fatal Outcome
1
2006
280
0.020
 Why?
Protein Processing, Post-Translational
1
2007
394
0.020
 Why?
Apolipoprotein B-100
1
2004
8
0.010
 Why?
Angina Pectoris
1
2004
63
0.010
 Why?
Solubility
1
2004
221
0.010
 Why?
Immunohistochemistry
1
2006
1604
0.010
 Why?
Health Care Surveys
1
2004
541
0.010
 Why?
Odds Ratio
1
2004
953
0.010
 Why?
Young Adult
1
2016
10400
0.010
 Why?
Echocardiography
2
1997
563
0.010
 Why?
Electrophysiology
1
1982
198
0.010
 Why?
Vascular Surgical Procedures
1
2004
256
0.010
 Why?
Adolescent
2
2016
17724
0.010
 Why?
Vascular Resistance
1
1982
337
0.010
 Why?
Thorax
1
1997
40
0.010
 Why?
Phosphorus Isotopes
1
1995
7
0.010
 Why?
Infusions, Parenteral
1
1994
36
0.010
 Why?
Basal Metabolism
1
1994
44
0.010
 Why?
Cardiac Pacing, Artificial
1
1995
78
0.010
 Why?
Substrate Specificity
1
1995
349
0.010
 Why?
Lung
1
2006
3497
0.010
 Why?
Glycolysis
1
1995
223
0.010
 Why?
Rats, Sprague-Dawley
1
1997
2139
0.010
 Why?
Rats
1
1997
4829
0.010
 Why?
Cardiomegaly
1
1990
158
0.000
 Why?
Hydrogen-Ion Concentration
1
1990
502
0.000
 Why?
Cardiomyopathy, Dilated
1
1990
348
0.000
 Why?
Magnetic Resonance Imaging
1
1990
3013
0.000
 Why?
Schwartz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (478) concept(s)
_
Co-Authors Expand Description
See all (17) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)